SignatureFD’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-150
| Closed | -$8.89K | – | 3235 |
|
|
2024
Q2 | $8.89K | Hold |
150
| – | – | ﹤0.01% | 2317 |
|
|
2024
Q1 | $8.63K | Buy |
+150
| New | +$8.63K | ﹤0.01% | 2353 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$4K | – | 3134 |
|
|
2021
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 2461 |
|
|
2020
Q3 | – | Sell |
-300
| Closed | -$22K | – | 2592 |
|
|
2020
Q2 | $22K | Hold |
300
| – | – | ﹤0.01% | 1290 |
|
|
2020
Q1 | $14K | Hold |
300
| – | – | ﹤0.01% | 1361 |
|
|
2019
Q4 | $19K | Hold |
300
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 1352 |
|
|
2019
Q2 | $16K | Hold |
300
| – | – | ﹤0.01% | 1261 |
|
|
2019
Q1 | $17K | Hold |
300
| – | – | ﹤0.01% | 1231 |
|
|
2018
Q4 | $13K | Hold |
300
| – | – | ﹤0.01% | 1269 |
|
|
2018
Q3 | $21K | Hold |
300
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q2 | $17K | Hold |
300
| – | – | ﹤0.01% | 1208 |
|
|
2018
Q1 | $17K | Buy |
+300
| New | +$17K | ﹤0.01% | 1080 |
|
|
2015
Q3 | – | Sell |
-1,588
| Closed | -$144K | – | 1236 |
|
|
2015
Q2 | $144K | Hold |
1,588
| – | – | 0.03% | 172 |
|
|
2015
Q1 | $126K | Buy |
1,588
+220
| +16% | +$17.5K | 0.03% | 175 |
|
|
2014
Q4 | $86K | Buy |
+1,368
| New | +$86K | 0.02% | 222 |
|
|
2014
Q2 | – | Sell |
-340
| Closed | -$14K | – | 880 |
|
|
2014
Q1 | $14K | Hold |
340
| – | – | 0.01% | 364 |
|
|
2013
Q4 | $13K | Hold |
340
| – | – | ﹤0.01% | 410 |
|
|
2013
Q3 | $11K | Buy |
+340
| New | +$11K | ﹤0.01% | 397 |
|